Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quetiapine for Delirium Prophylaxis in High-risk Critically Ill Patients

NCT02612948 is registered in ClinicalTrials.gov with University of Tennessee Graduate School of Medicine as lead sponsor.

NCT NCT02612948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02612948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quetiapine for Delirium Prophylaxis in High-risk Critically Ill Patients
Lead sponsor
University of Tennessee Graduate School of Medicine
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2013
Completion date
June 30, 2014
Enrollment
82 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psychomotor agitation